Search for: "In re: Abbott Laboratories" Results 21 - 40 of 216
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Apr 2022, 8:12 pm by Bill Marler
Here are the whistleblower documents – Redacted Confidential Disclosure re Abbott Laboratories – 10-19-2021_Redacted (1) Please read the above and ask the question: is this how infant formula should be manufactured? [read post]
6 Nov 2014, 4:15 pm by Sabrina I. Pacifici
 November 5, 2014 KEY FINDINGS Pepsi, IKEA, AIG, Coach, Deutsche Bank, Abbott Laboratories and nearly 340 other companies have secured secret deals from Luxembourg that allowed many of them to slash their global tax bills. [read post]
6 Aug 2013, 12:18 pm by Michelle Yeary
            So how does In re Darvocet differ from In re Abbott Laboratories? [read post]
15 May 2022, 9:06 pm by Bill Marler
 Redacted Confidential Disclosure re Abbott Laboratories – 10-19-2021_Redacted (1) The whistle blower document outlines many problems at the Abbott production facility in Sturgis, Michigan, including the following: The Falsification of Records – On multiple occasions, and in various ways, records have been knowingly falsified. [read post]
29 Apr 2022, 1:53 pm by Bill Marler
Here are the whistleblower documents – Redacted Confidential Disclosure re Abbott Laboratories – 10-19-2021_Redacted (1) Please read the above and ask the question: is this how infant formula should be manufactured? [read post]
21 Oct 2016, 7:47 am by Ben Vernia
  For example, Omnicare allegedly solicited substantial contributions from Abbott and other pharmaceutical manufacturers to its “Re*View” program. [read post]
13 Oct 2009, 9:59 pm
As part of the effort to encourage these companies to pool their patents, MSF has launched an e-mail writing campaign calling on Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline, Merck & Co, Pfizer, and Sequoia Pharmaceuticals to place specific HIV drug patents... [read post]
28 Apr 2022, 11:15 am by Bill Marler
 Here is the material – Redacted Confidential Disclosure re Abbott Laboratories – 10-19-2021_Redacted (1) The release of this report follows DeLauro’s letter to the Inspector General of the Department of Health and Human Services (HHS), Office of Inspector General (OIG), Christi A. [read post]
1 Feb 2012, 11:15 am by Sean Wajert
Abbott Laboratories, et al., No. 2:10-cv-03242 (E.D. [read post]
18 Jun 2014, 1:00 pm
One of the more well-known products is AndroGel, from AbbVie, a subsidiary of Abbott Laboratories. [read post]
23 Oct 2012, 4:01 am by Sean Wajert
See In re Abbott Laboratories Inc., No. 12-8020 (7th Cir. 10/16/12). [read post]
5 Dec 2011, 8:59 am by <a href=''>Kara M. Maciel</a>
Abbott Laboratories, Inc., the Eastern District of Pennsylvania issued the latest ruling in the ongoing dispute over whether pharmaceutical sales representatives are exempt from the overtime requirements of the FLSA. [read post]
26 Jan 2011, 9:52 am by Rebecca Tushnet
Lacey, Division Counsel, Abbott Laboratories I came in near the end, but Lacey emphasized that a marketer needs to know the difference between labeling (FDA authority) and other material (FTC)—if you detail to pediatricians about foods with nutritional benefits, for example, FDA largely prohibits nutrient claims for kids under 2. [read post]
11 Sep 2023, 4:00 am by Administrator
Canadian Securities Law Canadian Class Actions MonitorSaskatchewan Court of Appeal: Serial Certification Attempts Abusive In Abbott Laboratories, Ltd. v Spicer, the Saskatchewan Court of Appeal permanently stayed a proposed class action that was the last of five proposed national class actions concerning the drug sibutramine. [read post]